Model-based evaluation of ipilimumab dosage regimen in patients with advanced melanoma
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: D. Dai, C. Wu, S. M. Parker, M. N. Jure-Kunkel, M. Pfister, D. Berman, A. Roy
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: ipilimumab, advanced melanoma, CTLA-4 blockade, pharmacokinetics, exposure-response relationship, trough concentration, immune-related adverse events, tumor response, nonlinear mixed-effects models, dose selection, immune checkpoint inhibitors, budesonide, IL-2 therapy, drug safety and efficacy
Open Access status: closed
OpenAlex ID: W20200451
